The expression level of PRC1 may serve as a predictive biomarker for the anti-tumor effectiveness of PLK1 inhibitors, further underscoring the importance of PRC1 research in clear ccRCC. Here, PLK1 is linked to nonpapillary renal cell carcinoma.